Clinical Trials Insight: 700033898
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2009
At a glance
- Drugs Namilumab (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Multiple sclerosis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- 18 Jun 2009 Status changed from planning to recruiting, as reported in a Micromet Inc media release.
- 26 May 2008 New trial record.